Panagora Asset Management Inc Neogenomics Inc Transaction History

Panagora Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$6.45 - $12.07 $3,218 - $6,022	499 Added 3.05%	16,878 $155,000
Q4 2021 Feb 10, 2022	SELL	$30.49 - $48.49 $199,160 - $316,736	-6,532 Reduced 28.51%	16,379 $559,000
Q2 2021 Aug 11, 2021	SELL	$36.62 - $51.69 $185,150 - $261,344	-5,056 Reduced 18.08%	22,911 $1.04 Million
Q1 2021 May 12, 2021	SELL	$41.56 - $59.88 $686,779 - $989,517	-16,525 Reduced 37.14%	27,967 $1.35 Million
Q4 2020 Feb 10, 2021	SELL	$36.08 - $56.47 $202,553 - $317,022	-5,614 Reduced 11.2%	44,492 $2.4 Million
Q3 2020 Nov 13, 2020	SELL	$33.26 - $40.48 $3.2 Million - $3.89 Million	-96,150 Reduced 65.74%	50,106 $1.85 Million
Q2 2020 Aug 12, 2020	SELL	$24.21 - $31.02 $4,164 - $5,335	-172 Reduced 0.12%	146,256 $4.53 Million
Q4 2019 Feb 12, 2020	BUY	$18.96 - $29.84 $31,189 - $49,086	1,645 Added 1.14%	146,428 $4.28 Million
Q2 2019 Aug 09, 2019	BUY	$19.57 - $24.1 $2.56 Million - $3.15 Million	130,812 Added 936.31%	144,783 $3.18 Million
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $157,034 - $258,463	13,971 New	13,971 $176,000

293

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.8B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.